DEFINITIVE PROXY STATEMENT

Company

REGENERON PHARMACEUTICALS, INC.

Filed

April 27, 2010

Period of Report

June 11, 2010

Accession Number

0001206774-10-001040

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →